Role of plasma and liver cholesterol- and lipoprotein-metabolism determinants in LpX formation in the mouse

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 6, 2007, Pages 979-988

  Bravo, Ignacio ^a   Amigo, Ludwig ^a   Cohen, David E ^b   Nervi, Flavio ^a   Rigotti, Attilio ^a   Francone, Omar ^c   Zanlungo, Silvana ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c PFIZER INC   (United States)

Author keywords

Cholestasis; Hypercholesterolemia; Lipoprotein X

Indexed keywords

ABC TRANSPORTER A1; LIPOPROTEIN X; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID; SCAVENGER RECEPTOR BI; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CHOLESTASIS; CHOLESTEROL LIVER LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIVER SINUSOID; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTASIS; CHOLESTEROL; FEMALE; GENE EXPRESSION REGULATION; HYPERCHOLESTEROLEMIA; LIPOPROTEIN-X; LIPOPROTEINS, HDL; LIPOPROTEINS, VLDL; LIVER; MICE; MICE, KNOCKOUT; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHOLIPIDS; SCAVENGER RECEPTORS, CLASS B;

MURINAE; MUS;

EID: 34247330998     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2007.02.010     Document Type: Article

References (62)

1. Ritland S. The abnormal "lipoprotein of cholestasis", lipoprotein-X. Scand. J. Gastroenterol. 10 (1975) 785-789
2. O K., and Frohlich J. Role of lecithin:cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in lipoprotein-X in vitro. J. Lipid Res. 36 (1995) 2344-2354
3. Elferink R.P., Ottenhoff R., van Marle J., Frijters C.M., Smith A.J., and Groen A.K. Class III P-glycoproteins mediate the formation of lipoprotein X in the mouse. J. Clin. Invest. 102 (1998) 1749-1757
4. Manzato E., Fellin R., Baggio G., Walch S., Neubeck W., and Seidel D. Formation of lipoprotein-X. Its relationship to bile compounds. J. Clin. Invest. 57 (1976) 1248-1260
5. De Vos R., and Desmet V.J. Morphologic changes of the junctional complex of the hepatocytes in rat liver after bile duct ligation. Br. J. Exp. Pathol. 59 (1978) 220-227
6. Easter D.W., Wade J.B., and Boyer J.L. Structural integrity of hepatocyte tight junctions. J. Cell Biol. 96 (1983) 745-749
7. Metz J., Aoki A., Merlo M., and Forssmann W. Morphological alterations and functional changes of interhepatocellular junctions induced by bile duct ligation. Cell Tissue Res. 182 (1977) 299-310
8. Seidel D., Buff H.U., Fauser U., and Bleyl U. On the metabolism of lipoprotein-X (LP-X). Clin. Chim. Acta 66 (1976) 195-207
9. Rothblat G., de la Llera-Moya M., Atger V., Kellner-Weibel G., Williams D.L., and Phillips M.C. Cell cholesterol efflux: integration of old and new observations provides new insights. J. Lipid Res. 40 (1999) 781-796
10. Yokoyama S. Apolipoprotein-mediated cellular cholesterol efflux. Biochim. Biophys. Acta 1392 (1998) 1-15
11. Langmann T., Kluchen J., Reil M., Liebisch G., Luciani M.F., Chimini G., Kaminski W.E., and Schmitz G. Molecular cloning of the human ATP-binding cassette transport 1 (hABC1): evidence of sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 257 (1999) 29-33
12. Basso F., Freeman L., Knapper C.L., Remaley A., Stonik J., Neufeld E.B., Tansey T., Amar M.J., Fruchart-Najib J., Duverger N., Santamarina-Fojo S., and Brewer Jr. H.B. Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations. J. Lipid Res. 44 (2003) 296-302
13. Haghpassand M., Bourassa P.A., Francone O.L., and Aiello R.J. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J. Clin. Invest. 108 (2001) 1315-1320
14. Neufeld E.B., Demosky Jr. S.J., Stonik J.A., Combs C., Remaley A.T., Duverger N., Santamarina-Fojo S., and Brewer Jr. H.B. The ABCA1 transporter functions on the basolateral surface of hepatocytes. Biochem. Biophys. Res. Commun. 297 (2002) 974-979
15. Rigotti A., Miettinen H.E., and Krieger M. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr. Rev. 24 (2003) 357-387
16. Ji Y., Jian B., Wang N., Sun Y., Moya M.L., Phillips M.C., Rothblat G.H., Swaney J.B., and Tall A.R. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272 (1997) 20982-20985
17. Landschulz K.T., Pathak R.K., Rigotti A., Krieger M., and Hobbs H.H. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J. Clin. Invest. 98 (1996) 984-995
18. 3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor. J. Biol. Chem. 275 (2000) 29993-30001
19. Yancey P.G., de la Llera-Moya G.M., Swarnakar S., Monzo P., Klein S.M., Connelly M.A., Johnson W.J., Williams D.L., and Rothblat G.H. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J. Biol. Chem. 275 (2000) 36596-36604
20. Carlson L.A., and Philipson B. Fish-eye disease. A new familial condition with massive corneal opacities and dyslipoproteinaemia. Lancet 2 (1979) 922-924
21. Fielding C.J., and Fielding P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36 (1995) 211-228
22. Glomset J.A., Norum K.R., and King W. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: lipid composition and reactivity in vitro. J. Clin. Invest. 49 (1970) 1827-1837
23. Torsvik H., Berg K., Magnani H.N., McConathy W.J., Alaupovic P., and Gjone E. Identification of the abnormal cholestatic lipoprotein (LP-X) in familial lecithin:cholesterol acyltransferase deficiency. FEBS Lett. 24 (1972) 165-168
24. Braun A., Zhang S., Miettinen H.E., Ebrahim S., Holm T.M., Vasile E., Post M.J., Yoerger D.M., Picard M.H., Krieger J.L., Andrews N.C., Simons M., and Krieger M. Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7283-7288
25. Trigatti B., Rayburn H., Viñals M., Braun A., Miettinen H., Penman M., Hertz M., Schrenzel M., Amigo L., Rigotti A., and Krieger M. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular physiology. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9322-9327
26. Zhu X., Herzenberg A.M., Eskandarian M., Maguire G.F., Scholey J.W., Connelly P.W., and Ng D.S. A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy. Am. J. Pathol. 165 (2004) 1269-1278
27. Breckenridge W.C. The catabolism of very low density lipoproteins. Can. J. Biochem. Cell Biol. 63 (1985) 890-897
28. Gibbons G.F., Wiggins D., Brown A.M., and Hebbachi A.M. Synthesis and function of hepatic very-low-density lipoprotein. Biochem. Soc. Trans. 32 (2004) 59-64
29. Fredrickson D.S., Loud A.V., Hinkelman B.T., Schneider H.S., and Frantz Jr. I.D. The effect of ligation of the common bile duct on cholesterol synthesis in the rat. J. Exp. Med. 99 (1954) 43-53
30. Weis H.J., and Dietschy J.M. Failure of bile acids to control hepatic cholesterogenesis: evidence for endogenous cholesterol feedback. J. Clin. Invest. 48 (1969) 2398-2408
31. Kattermann R., and Creutzfeldt W. The effect of experimental cholestasis on the negative feedback regulation of cholesterol synthesis in rat liver. Scand. J. Gastroenterol. 5 (1970) 337-342
32. Weis H.J., and Dietschy J.M. Presence of intact cholesterol feedback mechanism in the liver in biliary stasis. Gastroenterology 61 (1971) 77-84
33. Harry D.S., Dini M., and McIntyre N. Effect of cholesterol feeding and biliary obstruction on hepatic cholesterol biosynthesis in the rat. Biochim. Biophys. Acta 296 (1973) 209-220
34. Dueland S., Reichen J., Everson G.T., and Davis R.A. Regulation of cholesterol and bile acid homoeostasis in bile-obstructed rats. Biochem. J. 280 (1991) 373-377
35. Walli A.K., and Seidel D. Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia, uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat. J. Clin. Invest. 74 (1984) 867-879
36. McNeish J., Aiello R.J., Guyot D., Turi T., Gabel C., Aldinger C., Hoppe K.L., Roach M.L., Royer L.J., de Wet J., Broccardo C., Chimini G., and Francone O.L. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4245-4250
37. Rigotti A., Trigatti B.L., Penman M., Rayburn H., Herz J., and Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 12610-12615
38. Raabe M., Veniant M.M., Sullivan M.A., Zlot C.H., Bjorkegren J., Nielsen L.B., Wong J.S., Hamilton R.L., and Young S.G. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J. Clin. Invest. 103 (1999) 1287-1298
39. Zanlungo S., Amigo L., Mendoza H., Miquel J.F., Vio C., Glick J.M., Rodriguez A., Kozarsky K., Quiñones V., Rigotti A., and Nervi F. Sterol carrier protein 2 gene transfer changes lipid metabolism and enterohepatic sterol circulation in mice. Gastroenterology 119 (2000) 1708-1719
40. Nervi F., Del Pozo R., Covarrubias C.F., and Ronco B.O. The effect of progesterone on the regulatory mechanisms of biliary cholesterol secretion in the rat. Hepatology 3 (1983) 360-367
41. Nervi F., Marinovic I., Rigotti A., and Ulloa N. Regulation of biliary cholesterol secretion. Functional relationship between the canalicular and sinusoidal cholesterol secretory pathways in the rat. J. Clin. Invest. 82 (1988) 1818-1825
42. Baginski E.S., Foa P.P., and Zak B. Microdetermination of inorganic phosphate, phospholipids, and total phosphate in biologic materials. Clin. Chem. 13 (1967) 326-332
43. Chung B.H., Wilkinson T., Geer J.C., and Segrest J.P. Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J. Lipid Res. 21 (1980) 284-291
44. Jokinen E.V., Landschulz K.T., Wyne K.L., Ho Y.K., Frykman P.K., and Hobbs H.H. Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J. Biol. Chem. 269 (1994) 26411-26418
45. Francone O.L., Gong E.L., Ng D.S., Fielding C.J., and Rubin E.M. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism. J. Clin. Invest. 96 (1995) 1440-1448
46. Dietschy J.M., and Spady D.K. Measurement of rates of cholesterol synthesis using tritiated water. J. Lipid Res. 25 (1984) 1469-1476
47. Wagner M., Fickert P., Zollner G., Fuchsbichler A., Silbert D., Tsybrovskyy O., Zatloukal K., Guo G.L., Schuetz J.D., Gonzalez F.J., Marschall H.U., Denk H., and Trauner M. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 125 (2003) 825-838
48. Groen A.K., Bloks V.W., Bandsma R.H., Ottenhoff R., Chimini G., and Kuipers F. Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL. J. Clin. Invest. 108 (2001) 843-850
49. Francone O.L., Subbaiah P.V., van Tol A., Royer L., and Haghpassand M. Abnormal phospholipid composition impairs HDL biogenesis and maturation in mice lacking Abca1. Biochemistry 42 (2003) 8569-8578
50. Chisholm J.W., Nation P., Dolphin P.J., and Agellon L.B. High plasma cholesterol in drug-induced cholestasis is associated with enhanced hepatic cholesterol synthesis. Am. J. Physiol. 276 (1999) G1165-G1173
51. Barr V.A., and Hubbard A.L. Newly synthesized hepatocyte plasma membrane proteins are transported in transcytotic vesicles in the bile duct-ligated rat. Gastroenterology 105 (1993) 554-571
52. Felker T.E., Hamilton R.L., and Havel R.J. Secretion of lipoprotein-X by perfused livers of rats with cholestasis. Proc. Natl. Acad. Sci. U. S. A. 75 (1978) 3459-3463
53. Zanlungo S., Rigotti A., and Nervi F. Hepatic cholesterol transport from plasma into bile: implications for gallstone disease. Curr. Opin. Lipidol. 15 (2004) 279-286
54. Lambert G., Sakai N., Vaisman B.L., Neufeld E.B., Marteyn B., Chan C.C., Paigen B., Lupia E., Thomas A., Striker L.J., Blanchette-Mackie J., Csako G., Brady J.N., Costello R., Striker G.E., Remaley A.T., Brewer Jr. H.B., and Santamarina-Fojo S. Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice. J. Biol. Chem. 276 (2001) 15090-15098
55. Wu M.K., and Cohen D.E. Phosphatidylcholine transfer protein regulates size and hepatic uptake of high-density lipoproteins. Am. J. Physiol.: Gastrointest. Liver Physiol. 289 (2005) G1067-G1074
56. Agorastos J., Fox C., Harry D.S., and McIntyre N. Lecithin-cholesterol acyltransferase and the lipoprotein abnormalities of obstructive jaundice. Clin. Sci. Mol. Med. 54 (1978) 369-379
57. Williams D.R., Barter P.J., and Mackinnon A.M. Serum lecithin:cholesterol acyltransferase activity in the bile duct-ligated rat. Digestion 21 (1981) 273-278
58. Stedman C.A., Liddle C., Coulter S.A., Sonoda J., Alvarez J.G., Moore D.D., Evans R.M., and Downes M. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2063-2068
59. Guo G.L., Lambert G., Negishi M., Ward J.M., Brewer Jr. H.B., Kliewer S.A., Gonzalez F.J., and Sinal C.J. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J. Biol. Chem. 278 (2003) 45062-45071
60. Chen C.H., and Albers J.J. Interspecies activation of lecithin-cholesterol acyltransferase by apolipoprotein A-I isolated from the plasma of humans, horses, sheep, goats and rabbits. Biochim. Biophys. Acta 753 (1983) 40-46
61. Sporstol M., Tapia G., Malerod L., Mousavi S., and Berg T. Pregnane X receptor-agonists down-regulate hepatic ATP-binding cassette transporter A1 and scavenger receptor class B type I. Biophys. Res. Commun. 331 (2005) 1533-1541
62. Malerod L., Sporstol M., Juvet L.K., Mousavi S.A., Gjoen T., Berg T., Roos N., and Eskild W. Bile acids reduce SR-BI expression in hepatocytes by a pathway involving FXR/RXR, SHP, and LRH-1. Biochem. Biophys. Res. Commun. 336 (2005) 1096-1105